- TWD52.11bn
- TWD48.63bn
- TWD7.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.07 | ||
| Price to Tang. Book | 9.91 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6,965.57 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -22.69% | ||
| Return on Equity | -19.66% | ||
| Operating Margin | -24689.84% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | n/a | 9.41 | 15.04 | 6.44 | 7.48 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Polaris Group is a Cayman Islands-based biopharmaceutical company, which is engaged in advanced therapies, primarily focusing on metabolic related diseases. The Company’s drug candidate, Pegargiminase (ADI-PEG 20), is advancing through the biologics license applications (BLA) - enabling stage and clinical development. Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Pegargiminase is designed to disrupt cancer cell metabolism, providing a novel approach to treating a range of cancers heavily influenced by metabolic pathways. The Company’s product pipeline also includes peptide drugs, such as the Semaglutide-related products.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 9th, 2006
- Public Since
- February 15th, 2016
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Taiwan Stock Exchange- Shares in Issue
- 744,420,732
- Address
- Ugland House, GRAND CAYMAN, KY1-1104
- Web
- https://www.polaris-group.com/
- Phone
- Contact
- Kay Huang
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 6550
Q1 2024 Polaris Group Earnings Release
April 2024 Polaris Group Corporate Sales Release
May 2024 Polaris Group Corporate Sales Release
June 2024 Polaris Group Corporate Sales Release
July 2024 Polaris Group Corporate Sales Release
Q2 2024 Polaris Group Earnings Release
August 2024 Polaris Group Corporate Sales Release
September 2024 Polaris Group Corporate Sales Release
Similar to 6550
Abnova Taiwan
Taiwan Stock Exchange
Applied BioCode
Taiwan Stock Exchange
Energenesis Biomedical Co
Taiwan Stock Exchange
Kim Forest Enterprise Co
Taiwan Stock Exchange
PHARMAESSENTIA
Taiwan Stock Exchange
FAQ
What is the Polaris share price?
As of Today at 19:16 UTC, shares in Polaris are trading at TWD70.00. This share price information is delayed by 15 minutes.
How has the Polaris share price performed this year?
Shares in Polaris last closed at TWD70.00 and the price had moved by -30% over the past 365 days. In terms of relative price strength the Polaris share price has underperformed the FTSE Developed Asia Pacific Index by -29.52% over the past year.
What are the analyst and broker recommendations for Polaris?
There is no consensus recommendation for this security.
What is the Polaris dividend yield?
Polaris does not currently pay a dividend.
Does Polaris pay a dividend?
Polaris does not currently pay a dividend.
When does Polaris next pay dividends?
Polaris does not currently pay a dividend.
How do I buy Polaris shares?
To buy shares in Polaris you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Polaris?
As of the previous close price of TWD70.00, shares in Polaris had a market capitalisation of TWD52.11bn.
Where are Polaris shares listed?
Here are the trading details for Polaris:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6550
What kind of share is Polaris?
Based on an overall assessment of its quality, value and momentum Polaris is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Polaris share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Polaris share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Polaris. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -16.37%.
As of the last closing price of TWD70.00, shares in Polaris were trading -7.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Polaris PE Ratio?
The Polaris PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD70.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Polaris?
We do not have data on Polaris' directors